Search for: "CytoDyn, Inc."
Results 1 - 14
of 14
Sorted by Relevance
|
Sort by Date
20 Dec 2022, 9:59 am
The Securities and Exchange Commission today charged Nader Pourhassan, the former CEO of CytoDyn Inc., with fraud and insider trading in connection with providing misleading information to shareholders about the progress of a clinical research treatment…Read the Full Press ReleaseHave a securities law question? [read post]
20 Oct 2021, 6:11 am
CytoDyn Inc., C.A. [read post]
17 Nov 2021, 6:51 am
CytoDyn Inc., the Delaware Court of Chancery, in an opinion by Vice Chancellor Slights, upheld a board’s decision to exclude stockholder nominees from being considered at CytoDyn’s annual meeting based on deficiencies in the stockholders’ notice required by the company’s advance notice bylaw. [read post]
24 Oct 2021, 12:03 pm
CytoDyn Inc., et al., No. 2021-0728-JRS, opinion issued (Del. [read post]
8 Dec 2021, 6:08 am
Slights III issued a post-trial decision affirming the CytoDyn Inc. board of directors’ decision to reject a stockholder nomination of directors for failure to supply information required by the company’s advance notice bylaw. [read post]
28 Nov 2021, 7:58 am
CytoDyn Inc., No. 2021-CV-0728-JRS (Del. [read post]
19 Jul 2022, 2:04 pm
Servs., Inc., 500 U.S. 90, 99 (1991). [read post]
21 Dec 2021, 6:00 am
CytoDyn Inc., 2021 WL 4775410 (Del. [read post]
1 May 2019, 12:16 pm
From February 2012 until December 2012 Meier was associated with Symetra Investment Services, Inc. [read post]
28 Jun 2022, 9:01 pm
Chris-Craft Indus., Inc. [read post]
5 Feb 2019, 10:46 am
., CytoDyn, Inc., Lifeway Foods, Inc. and Digital Turbine, Inc. [read post]
15 Jan 2024, 9:01 pm
AIM Immunotech Inc., et al. [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and de-branding of… [read post]
9 May 2023, 9:01 pm
There is reason to believe the SEC’s new universal proxy Rule 14a-19 will result in more stockholder nominees being elected to the boards of public companies. [read post]